8-K: Fortitude Mining Reports Strong Q2, Invests in HeartSciences

Sentiment:

Current Report (Form 8-K) / Regulation FD Disclosure


Fortitude Mining Holdings announced robust Q2 2026 financial and operational results, including $20.9 million in revenue and $8.5 million in Adjusted EBITDA, alongside a strategic investment in HeartSciences Inc.

Capital raiseFortitude purchased approximately $1,000,000 of HeartSciences common stock in a private placement on August 12, 2026, at a VWAP of $2.43 per share. This investment supports HeartSciences' operating expenses and reflects Fortitude's commitment to the merger.

Summary

  • Fortitude Mining Holdings reported strong financial and operational performance for the quarter ended June 30, 2026.
  • Revenue for the quarter was $20.9 million, with Adjusted EBITDA reaching $8.5 million.
  • The company mined approximately 33,646 ZEC during the quarter, maintaining an average operating hash rate of 4.0 GSol/s.
  • Fortitude expanded its power portfolio to over 60 MW across seven sites.
  • A strategic investment of approximately $1,000,000 was made in HeartSciences common stock via a private placement.
  • The proposed business combination between Fortitude and HeartSciences is expected to close in the second half of 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, primarily due to Fortitude's strong Q2 financial and operational highlights and its strategic investment in HeartSciences, signaling confidence in the merger.

Positives

  • Strong Q2 revenue of $20.9 million.
  • Robust Adjusted EBITDA of $8.5 million, indicating healthy profitability.
  • Significant ZEC mining volume of approximately 33,646 units.
  • Expansion of owned-and-operated power capacity to over 60 MW.
  • Strategic investment of $1,000,000 in HeartSciences common stock, demonstrating commitment to the merger.
  • Fortitude now owns approximately 9.4% of HeartSciences' outstanding common stock.

Negatives

  • The company's net loss for Q2 2026 was $(9.5) million, though this is offset by significant non-cash items and adjusted for in EBITDA.
  • The filing contains numerous cautionary statements regarding forward-looking information and the risks associated with the proposed transaction and cryptocurrency markets.

Risks

  • The risk that the Proposed Transaction may not be completed on the anticipated timeline or at all.
  • Failure to satisfy closing conditions for the Proposed Transaction, including obtaining requisite shareholder approval.
  • Market or macroeconomic conditions that could adversely affect HeartSciences, Fortitude, or the combined company.
  • Risks related to the integration of the two companies and the management of a newly public company.
  • Risks inherent in Fortitude's operations, including the highly volatile nature of Zcash and other cryptocurrency prices.
  • Significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally.

Future Outlook

The proposed business combination between Fortitude and HeartSciences is expected to close in the second half of 2026, aiming to bring Fortitude's digital asset mining platform to the public markets.

Management Comments

  • "This was a strong quarter for Fortitude and a clear demonstration of the momentum building in our vertically-integrated strategy," said Andrea Childs, CEO of Fortitude.
  • "As we work to advance toward the public markets via our proposed business combination with HeartSciences, we remain thrilled about the opportunity ahead and our ability to execute on it."
  • "Fortitude delivered a strong cash-flowing quarter in Q2, generating $20.9 million in revenue driven by continued ZEC hashprice and hashrate performance across our fleet," added Erik Ellingson, CFO of Fortitude.
  • "This translated into robust operating cash flow indicated by adjusted EBITDA of $8.5 million, reinforcing the strength of our ZEC-focused mining strategy as we continue to prepare to close our proposed business combination with HeartSciences."

Industry Context

StockSavvy.ai notes that this filing highlights the ongoing trend of consolidation and strategic partnerships within the digital asset mining sector, as companies seek to achieve scale and public market access. The investment in HeartSciences, an AI-powered medical technology company, suggests a diversification strategy or a belief in synergistic value creation beyond traditional mining operations.

Stakeholder Impact

  • Shareholders of HeartSciences will vote on the proposed business combination.
  • Fortitude's investment in HeartSciences may be viewed positively by HeartSciences shareholders as a sign of commitment to the merger.
  • The successful completion of the merger will result in a new publicly traded entity, impacting all shareholders of both companies.

Next Steps

  • Closing of the proposed business combination between Fortitude and HeartSciences, expected in H2 2026.
  • HeartSciences to mail definitive proxy statement and proxy card to shareholders for the special meeting related to the Proposed Transaction.
  • Potential filing of additional relevant materials with the SEC by HeartSciences concerning the Proposed Transaction.

Key Dates

DateDescription
2026-06-23Date of the Agreement and Plan of Merger between HeartSciences Inc. and Fortitude Mining Holdings, Inc.
2026-07-23HeartSciences filed its 2026 Annual Report on Form 10-K.
2026-07-27HeartSciences filed a preliminary proxy statement on Schedule 14A with the SEC.
2026-08-11End of the 30 trading day period for Volume Weighted Average Price calculation for HeartSciences common stock.
2026-08-12Fortitude and HeartSciences entered into a subscription agreement for Fortitude's purchase of HeartSciences common stock.
2026-08-18HeartSciences filed its Current Report on Form 8-K detailing outstanding shares of Common Stock.
2026-08-20Date of the Form 8-K filing and the press release announcing Q2 2026 financial and operating highlights.
2026-08-20Fortitude issued a press release announcing its financial and operating highlights for the quarter ended June 30, 2026.

Recommendation

hold

The filing presents strong operational and financial results for Fortitude, coupled with a strategic investment in HeartSciences, indicating positive momentum towards the merger. However, the inherent volatility of the cryptocurrency market and the uncertainties surrounding the completion of the merger warrant a cautious 'hold' stance until further clarity on the integration and future performance of the combined entity is available.

Keywords

digital asset mining, Zcash, cryptocurrency, merger, business combination, financial highlights, Adjusted EBITDA, hash rate

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.